Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer's disease

Psychopharmacology

Volumn 198, Issue 3, 2008, Pages 323-332

  Gianotti, Lorena R R ^a   Künig, Gabriella ^b   Faber, Pascal L ^a   Lehmann, Dietrich ^a   Pascual Marqui, Roberto D ^a   Kochi, Kieko ^a   Schreiter Gasser, Ursula ^c  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Praxis für Psychiatrie Rehalp   (Switzerland)

Author keywords

Alzheimer's disease; Cholinesterase inhibitors; EEG; LORETA functional imaging; Rivastigmine; Source localization; Spectral analysis

Indexed keywords

RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; FREQUENCY ANALYZER; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; INSULA; LOW RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; PARIETAL LOBE; PRIORITY JOURNAL; SPECTROSCOPY; SUBICULUM; TEMPORAL CORTEX; THREE DIMENSIONAL IMAGING; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PHENYLCARBAMATES; PSYCHOMOTOR PERFORMANCE;

EID: 44249100842     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1111-1     Document Type: Article

References (66)

1. Adler G, Brassen S (2001) Short-term rivastigmine treatment reduces EEG Slow-wave power in Alzheimer patients. Neuropsychobiology 43:273-276
2. Adler G, Brassen S, Chwalek K, Dieter B, Teufel M (2004) Prediction of treatment response to rivastigmine in Alzheimer's dementia. J Neurol Neurosur Ps 75:292-294
3. Almkvist O, Darreh-Shori T, Stefanova E, Spiegel R, Nordberg A (2004) Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients. Eur J Neurol 11:253-261
4. Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A (2001) Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dement Geriatr Cogn Disord 12:22-32
5. Babiloni C, Binetti G, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Hirata K, Lanuzza B, Miniussi C, Moretti DV, Nobili F, Rodriguez G, Romani GL, Salinari S, Rossini PM (2006a) Sources of cortical rhythms change as a function of cognitive impairment in pathological aging a multicenter study. Clin Neurophysiol 117:252-268
6. Babiloni C, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Lanuzza B, Miniussi C, Moretti DV, Nobili F, Pascual-Marqui RD, Rodriguez G, Romani GL, Salinari S, Zanetti O, Rossini PM (2006b) Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: responders vs. nonresponders. Neuroimage 31:1650-1665
7. Babiloni C, Cassetta E, Binetti G, Tombini M, Del Percio C, Ferreri F, Ferri R, Frisoni G, Lanuzza B, Nobili F, Parisi L, Rodriguez G, Frigerio L, Gurzi M, Presia A, Vernieri F, Eusebi F, Rossini PM (2007) Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease. Eur J Neurosci 25:3742-3757
8. Balkan S, Yaraş N, Mihçi E, Dora B, Aǧar A, Yargiçoǧlu P (2003) Effect of denepezil on EEG spectral analysis in Alzheimer's disease. Acta Neurol Belg 103:164-169
9. Bohnen NI, Kaufer DI, Hendrickson R, Ivanco LS, Lopresti BJ, Koeppe RA, Meltzer CC, Constantine G, Davis JG, Mathis CA, DeKosky ST, Moore RY (2005) Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosur Ps 76:315-319
10. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
11. Bradley KM, O'Sullivan VT, Soper NDW, Nagy Z, King EM-F, Smith AD, Shepstone BJ (2002) Cerebral perfusion SPECT correlated with Braak pathological stage in Alzheimer's disease. Brain 125:1772-1781
12. Brassen S, Adler G (2003) Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial. Pharmacopsychiatry 36:304-308
13. Buchan RJ, Nagata K, Yokoyama E, Langman P, Yuya H, Hirata Y, Hatazawa J, Kanno I (1997) Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. Electroenceph Clin Neurophysiol 103:409-417
14. Bullock R, Dengiz A (2005) Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years. Int J Clin Pract 59:817-822
15. Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA (2006) Alterations in memory networks in mild cognitive impairment and Alzheimer' disease: An independent component analysis. J Neurosci 26:10222-10231
16. Ceravolo R, Volterrani D, Tognoni G, Dell'gnello G, Manca G, Kiferle L, Rossi Logi C, Strauss HW, Mariani G, Murri L (2004) Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease. Clin Neuropharmacol 27:166-170
17. Collins DL, Neelin P, Peters TM, Evans AC (1994) Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192-205
18. Crouzier D, Baubichon D, Bourbon F, Testylier G (2006) Acetylcholine release, EEG spectral analysis, sleep staging and body temperature studies: a multiparametric approach on freely moving rats. J Neurosci Methods 151:159-167
19. Dickson J, Drury H, Van Essen DC (2001) 'The surface management system' (SuMS) database: A surface-based database to aid cortical surface reconstruction, visualization and analysis. Philos T Roy Soc B 356:1277-1292
20. Dierks T, Vesna J, Pascual-Marqui RD, Wahlund LO, Julin P, Linden DEJ, Maurer K, Winblad B, Nordberg A (2000) Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol 111:1817-1824
21. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL (2001) Practice parameter: management of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 56:1154-1166
22. Farlow M, Anand R, Messin J Jr, Hartman R, Veach J (2000) A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer' disease. Eur Neurol 44:236-241
23. Feldman HH, Lane R (2007) Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 78:1056-1063
24. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini'-mental state. A practical method for grading the cognitive state of patients' for the clinician. J Psychiat Res 12:189-198
25. Foundas AL, Leonard CM, Mahoney SM, Agee OF, Heilman KM (1997) Atrophy of the hippocampus, parietal cortex, and insula in Alzheimer's disease: a volumetric magnetic resonance imaging study. Neuropsychiatry Neuropsychol Behav Neurol 10:81-89
26. Frei E, Gamma A, Pascual-Marqui R, Lehmann D, Hell D, Vollenweider FX (2001) Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA). Hum Brain Mapp 4:152-165
27. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak KS (1990) The relationship between global and local changes in PET scans. J Cerebr Blood-Flow Metab 10:458-466
28. Gasser T, Bacher P, Mocks J (1982) Transformations towards the normal distribution of broad band spectral parameters of the EEG. Electroenceph Clin Neurophysiol 53:119-124
29. Geula C (1998) Abnormalities of neural circuitry in Alzheimer' disease: hippocampus and cortical cholinergic innervation. Neurology 51:18-29
30. Gianotti LRR, Künig G, Lehmann D, Faber PL, Pascual-Marqui RD, Kochi K, Schreiter-Gasser U (2007) Correlation between disease severity and brain electric LORETA tomography in Alzheimer's disease. Clin Neurophysiol 118:186-196
31. Grasby PM, Frith CD, Friston KJ, Simpson J, Fletcher PC, Frackowiak RS, Dolan RJ (1994) A graded task approach to the functional mapping of brain areas implicated in auditory-verbal memory. Brain 117:1271-1282
32. Gusnard DA, Raichle ME (2001) Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci 2:685-694
33. Hartikainen P, Soininen H, Partanen J, Helkala EL, Riekkinen P (1992) Aging and spectral analysis of EEG in normal subjects: a link to memory and CSF AChE. Acta Neurol Scand 86:148-155
34. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170
35. Jagust WJ, Eberling JL, Reed BR, Mathis CA, Budinger TF (1997) Clinical studies of cerebral blood flow in Alzheimer's disease. Ann NY Acad Sci 826:254-262
36. Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A (1998) Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. Neurosci Lett 254:85-88
37. Keita MS, Frankel-Kohn L, Bertrand N, Lecanu L, Monmaura P (2000) Acetylcholine release in the hippocampus of the urethane anaesthetised rat positively correlates with both peak theta frequency and relative power in the theta band. Brain Res 887:323-334
38. Kogan EA, Korczyn AD, Virchovsky RG, Klimovizky SS, Treves TA, Neufeld MY (2001) EEG changes during long-term treatment with donepezil in Alzheimer' disease patients. J Neural Transm 108:1167-1173
39. Kubicki S, Herrmann WM, Fichte K, Freund G (1979) Reflections on the topics: EEG frequency bands and regulation of vigilance. Pharmakopsychiatr Neuropsychopharmacol 12:237-245
40. Lehmann D, Skrandies W (1980) Reference-free identification of components of checkerboard-evoked multichannel potential fields. Electroenceph Clin Neurophysiol 48:609-621
41. Machulda MM, Ward HA, Borowski B, Gunter JL, Cha RH, O'Brien PC, Petersen C, Boeve BF, Knopman D, Tang-Wai DF, Ivnik RJ, Smith GE, Tangalos EG, Jack CR Jr. (2003) Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 61:500-506
42. Manes F, Springer J, Jorge R, Robinson RG (1999) Verbal memory impairment after left insular cortex infarction. J Neurol Neurosur Ps 67:532-534
43. Matsuda H (2001) Cerebral blood flow and metabolic abnormalities in Alzheimers disease. Ann Nucl Med 15:85-92
44. McKahnn G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health an Human Services Task Force on Alzheimer's disease. Neurology 34:939-944
45. Mega MS, Cummings JL, O'Connor SM, Dinov ID, Reback E, Felix J, Masterman DL, Phelps ME, Small GW, Toga AW (2001) Cognitive and metabolic responses to Metrifonate therapy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 14:63-68
46. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer' disease. Ann Neurol 42:85-94
47. Mulert C, Jäger L, Schmitt R, Bussfeld P, Pogarell O, Möller H-J, Juckel G, Hegerl U (2004) Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection. NeuroImage 22:83-94
48. Nichols TE, Holmes AP (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15:1-25
49. Nuwer MR, Comi G, Emerson R, Fuglsang-Frederiksen A, Guerit J-M, Hinrichs H, Ikeda A, Luccas FJ, Rappelsburger P (1998) IFCN standards for digital recording of clinical EEG. Electroenceph Clin Neurophysiol 106:259-261
50. Oakes TR, Pizzagalli DA, Hendrick AM, Horras KA, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Davidson RJ (2004) Functional coupling of simultaneous electrical and metabolic activity in the human brain. Hum Brain Mapp 21:257-270
51. Pascual-Marqui RD, Michel CM, Lehmann D (1994) Low resolution electromagnetic tomography: A new method for localizing electrical activity in the brain. Int J Psychophysiol 7:49-65
52. Pascual-Marqui RD, Lehmann D, Koenig T, Kochi K, Merlo MCG, Hell D, Koukkou M (1999) Functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatr Res-Neuroim 90:169-179
53. Paulesu E, Frith CD, Frackowiak RSJ (1993) The neural correlates of the verbal component of working memory. Nature 362:342-345
54. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. P Natl Acad Sci USA 98:676-682
55. Riekkinen P, Buzsaki G, Riekkinen Jr P, Soininen H, Partanen J (1991) The cholinergic system and EEG slow waves. Electroencephalogr Clin Neurophysiol 78:89-96
56. Shelley BP, Trimble MR (2004) The insular lobe of Reil-its anatamico-functional, behavioural and neuropsychiatric attributes in humans-review. World J Biol Psychiatry 5:176-200
57. Schreiter-Gasser U, Gasser T, Ziegler P (1993) Quantitative EEG analysis in early onset Alzheimer's disease: a controlled study. Electroencephalogr Clin Neurophysiol 86:15-22
58. Schreiter-Gasser U, Gasser T, Ziegler P (1994) Quantitative EEG analysis in early onset Alzheimer's disease: correlations with severity, clinical characteristics, visual EEG and CCT. Electroencephalogr Clin Neurophysiol 90:267-272
59. Small SA, Perera GM, DeLaPaz R, Mayeux R, Stern Y (1999) Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol 45:466-472
60. Stefanova E, Wall A, Almkvist O, Nilsson A, Forsberg A, Långström B, Nordberg A (2006) Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease. J Neural Transm 113:205-218
61. Talairach J, Tournoux P (1988) Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart: Thieme
62. Towle VL, Bolanos J, Suarez D, Tan K, Grzeszczuk R, Levin D, Cakmur R, Frank SA, Spire JP (1993) The spatial location of EEG electrodes: Locating the best-fitting sphere relative to cortical anatomy. Electroencephalogr Clin Neurophysiol 86:1-6
63. Vincent JL, Snyder AZ, Fox MD, Shannon BJ, Andrews JR, Raichle ME, Buckner RN (2006) Coherent spontaneous activity identifies a hippocampal-parietal memory network. J Neurophysiol 96:3517-3531
64. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-126
65. WHO (1993) The ICD-10 Classification of mental and behavioral disorders: diagnostic criteria for research. World Health Organization, Geneva, Switzerland
66. Worrell GA, Lagerlund TD, Sharbrough FW, Brinkmann BH, Busacker NE, Cicora KM, O'Brien TJ (2000) Localization of the epileptic focus by low-resolution electromagnetic tomography in patients with a lesion demonstrated by MRI. Brain Topogr 12:273-282